Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Non-Current Deffered Revenue (2023 - 2025)

Historic Non-Current Deffered Revenue for Generation Bio (GBIO) over the last 3 years, with Q3 2025 value amounting to $30.6 million.

  • Generation Bio's Non-Current Deffered Revenue fell 206.12% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year decrease of 206.12%. This contributed to the annual value of $29.2 million for FY2024, which is 3047.3% down from last year.
  • Latest data reveals that Generation Bio reported Non-Current Deffered Revenue of $30.6 million as of Q3 2025, which was down 206.12% from $30.4 million recorded in Q2 2025.
  • In the past 5 years, Generation Bio's Non-Current Deffered Revenue ranged from a high of $55.1 million in Q1 2023 and a low of $29.2 million during Q4 2024
  • Its 3-year average for Non-Current Deffered Revenue is $38.0 million, with a median of $34.4 million in 2024.
  • As far as peak fluctuations go, Generation Bio's Non-Current Deffered Revenue tumbled by 3330.1% in 2024, and later plummeted by 206.12% in 2025.
  • Generation Bio's Non-Current Deffered Revenue (Quarter) stood at $41.9 million in 2023, then tumbled by 30.47% to $29.2 million in 2024, then rose by 4.77% to $30.6 million in 2025.
  • Its Non-Current Deffered Revenue was $30.6 million in Q3 2025, compared to $30.4 million in Q2 2025 and $30.3 million in Q1 2025.